Quick Answer
Brand-name GLP-1 medications like Wegovy, Ozempic, Zepbound, and Mounjaro are FDA-approved finished drugs manufactured by Novo Nordisk and Eli Lilly. They cost $1,000 to $1,400 per month without insurance.
Compounded GLP-1 medications use the same FDA-registered active pharmaceutical ingredient (semaglutide or tirzepatide), prepared by state-licensed compounding pharmacies under sections 503A and 503B of the federal Food, Drug, and Cosmetic Act. They cost $179 to $549 per month. The compounded preparations are not FDA-approved as final products.
Both paths are legal when done correctly. Neither is automatically safer or better. The right choice depends on your insurance, your physician's clinical judgment, and your willingness to pay brand-name pricing.
Side-by-Side Comparison (2026)
| Feature | Brand-Name GLP-1 | Compounded GLP-1 |
|---|---|---|
| Examples | Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda | Compounded semaglutide, compounded tirzepatide, compounded liraglutide |
| Active ingredient source | Manufacturer-produced | FDA-registered active pharmaceutical ingredient |
| Final product FDA-approved | Yes | No |
| Manufacturer | Novo Nordisk, Eli Lilly | State-licensed 503A or 503B compounding pharmacy |
| Prescription required | Yes | Yes |
| Typical cash price (US, 2026) | $1,000 to $1,400 per month | $179 to $549 per month |
| Insurance coverage | Sometimes, with prior authorization | Almost never |
| HSA / FSA eligible | Yes | Yes (with prescription) |
| Clinical trial data | STEP, SURMOUNT, SELECT, SUSTAIN | None on the specific compounded preparation; data on the active ingredient |
| Quality controls | FDA-supervised manufacturing | State board of pharmacy oversight, USP standards, third-party testing at reputable pharmacies |
| Availability | Frequent shortages 2022 to 2025 | Generally available |
What "FDA-Approved" Actually Means
FDA approval means the finished drug product, the specific formulation, dose, and manufacturer, has gone through the full clinical trial and regulatory review process. For Wegovy and Zepbound, that included the STEP trial program and the SURMOUNT trial program, each enrolling thousands of patients.
What FDA approval does not mean:
The active ingredients in GLP-1 medications, semaglutide and tirzepatide, are FDA-registered substances. Licensed compounding pharmacies can legally use these ingredients to prepare medications in response to a valid prescription.
What "Compounded" Actually Means
Compounding has been part of US pharmacy practice for over a century. It is the preparation of a customized medication by a licensed pharmacist in response to a specific prescription. Compounding is regulated under two key sections of federal law:
When you receive compounded semaglutide or tirzepatide from a reputable telehealth platform, your prescription is dispensed by a 503A or 503B pharmacy. The active pharmaceutical ingredient is the same molecule used in brand-name medications. The dose, vehicle, and packaging may differ.
The finished compounded product is not FDA-approved. This is a meaningful distinction and a required disclosure.
Real Cost Differences (2026)
These are typical 2026 US cash prices, not insurance copays:
*Brand-name GLP-1 monthly cash price:*
*Compounded GLP-1 monthly cash price (through reputable telehealth):*
With insurance, brand-name copays vary wildly. Some patients pay $25 per month, others pay full retail because their plan excludes GLP-1s for weight loss. The Eli Lilly direct-to-patient and Novo Nordisk direct-to-patient programs offer reduced pricing in some cases, typically $349 to $499 per month for cash-paying patients without insurance.
Compounded pricing is more predictable because there is no insurance variable. You know the monthly cost before you start.
Safety Profile Comparison
The active ingredient is the same molecule. Side effects, contraindications, and warnings are the same regardless of whether the medication is brand-name or compounded.
Common side effects across both:
Serious risks across both (rare but require screening):
The practical safety difference between brand-name and compounded is not pharmacological. It is supply chain quality control.
Brand-name supply chain: Manufactured under FDA-supervised cGMP at a small number of large facilities, distributed through licensed wholesalers and pharmacies.
Compounded supply chain: Quality varies by pharmacy. A 503A pharmacy that is NABP-accredited and LegitScript certified, uses USP-grade ingredients, and tests every batch for potency and sterility is operating at a high standard. An unaccredited pharmacy with limited oversight is operating at a lower standard.
This is why the dispensing pharmacy matters as much as the prescription when you choose compounded GLP-1.
Who Should Choose Which
*Brand-name GLP-1 may be the better path if:*
*Compounded GLP-1 may be the better path if:*
For most cash-paying patients in 2026, compounded GLP-1 is the path that makes the math work. For most insured patients with a generous benefit, brand-name with a low copay is hard to beat.
Red Flags (Avoid These Sources)
Not every source of compounded GLP-1 is legitimate. Avoid:
A legitimate compounded GLP-1 source has:
1. A real medical questionnaire with clinical screening 2. A US-licensed physician who reviews your case before prescribing 3. A state-licensed 503A or 503B compounding pharmacy that ships your medication 4. Disclosure that the compounded product is not FDA-approved 5. Ongoing access to a clinician for dose adjustments and questions
Legal Status (US, 2026)
Compounding is legal under federal law. The FDA's 503A and 503B framework provides the regulatory structure. Each state board of pharmacy oversees the 503A pharmacies operating in its state.
In 2024, when the FDA officially removed semaglutide and tirzepatide from the drug shortage list, there was significant attention on whether mass compounding would continue. The current 2026 picture: compounding for individual patients with valid prescriptions remains legal. Mass-produced compounded versions sold without prescriptions are not legal and have been the target of FDA enforcement.
State medical boards regulate the physicians who prescribe compounded medications via telehealth. State pharmacy boards regulate the pharmacies that dispense them. The Ryan Haight Act sets federal rules for online prescribing of controlled substances (GLP-1s are not controlled substances, so this applies less directly, but the general principle of a legitimate physician-patient relationship still applies).
The Bottom Line
Brand-name GLP-1 medications are FDA-approved, expensive, and clinically well-studied. Compounded GLP-1 medications use the same active ingredient, are not FDA-approved as final products, and cost a fraction of brand-name pricing.
Both are legal. Both are legitimate clinical paths. Neither is automatically the right choice for your situation.
The quality of the prescribing physician and the dispensing pharmacy matter more than whether you choose brand-name or compounded. A board-certified physician who reviews your medical history and an accredited compounding pharmacy with batch testing are the safety standards to look for.
If you are considering a GLP-1 and want a physician-reviewed recommendation specific to your situation, start your 2-minute medical assessment at /quiz. A US-licensed physician will review your information, screen for contraindications, and recommend the right path for you.
For a deeper look at the specific medications, see our complete list of GLP-1 brands available in 2026, our tirzepatide vs semaglutide comparison, and our breakdown of GLP-1 costs without insurance.
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider. Compounded medications are not FDA-approved as final products. Individual results may vary.
Frequently Asked Questions
Is compounded semaglutide the same as Wegovy or Ozempic?
It shares the same active ingredient, semaglutide, but the final product is different. Wegovy and Ozempic are FDA-approved finished medications manufactured by Novo Nordisk. Compounded semaglutide is prepared by a state-licensed compounding pharmacy from FDA-registered active pharmaceutical ingredient. The final compounded product is not FDA-approved.
Is compounded GLP-1 medication legal?
Yes, when prepared by a licensed 503A or 503B compounding pharmacy in response to a valid prescription from a US-licensed physician. Compounded medications are legal under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. Products sold without a prescription, labeled 'research only,' or imported from offshore vendors are not legal.
Why does compounded GLP-1 cost so much less than brand-name?
Brand-name GLP-1s carry the cost of original clinical trials, FDA approval, large-scale manufacturing, and marketing. Compounded medications use FDA-registered active ingredient and are prepared in smaller batches at state-licensed pharmacies. The pricing reflects production cost, not the brand premium. Typical compounded pricing in 2026 is $179 to $549 per month, compared to $1,000 to $1,400 per month for brand-name versions without insurance.
Are compounded GLP-1 medications as effective as brand-name?
Per dose, the active ingredient is the same molecule. The clinical effect at equivalent dosing should be similar, though no head-to-head trial has compared brand-name and compounded versions. Quality varies by compounding pharmacy, which is why prescription through a US-licensed physician and dispensing by an accredited 503A or 503B pharmacy matters more for compounded than for brand-name.
Will my doctor or my health insurance cover compounded GLP-1?
Health insurance almost never covers compounded medications. Most patients pay out of pocket. The trade-off is that compounded pricing is often lower than the insurance copay for brand-name GLP-1s. HSA and FSA cards are typically accepted for prescription compounded medications.
How do I know if a compounded GLP-1 source is legitimate?
Three checks. First, a US-licensed physician reviews your medical history and writes a real prescription. Second, the pharmacy is a state-licensed 503A or 503B compounding pharmacy, ideally NABP-accredited and LegitScript certified. Third, every batch is third-party tested for potency and sterility. Anything sold without a prescription, marketed as 'research only,' or shipped from outside the US is not legitimate.
All Majesta Health medical content is clinically reviewed before publication by US-licensed physicians affiliated with our clinical infrastructure partner, MD Integrations (MDI). Reviewers hold active state medical licenses, are board-certified in primary care or obesity medicine, and specialize in GLP-1 receptor agonist therapy for chronic weight management. MDI is LegitScript certified and SOC 2 Type II accredited.
- US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
- Board-certified in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across all 50 US states and DC through the MD Integrations Medical Services Organization
- Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited, 503A and 503B compounding)